Denise M. Sloan, PhD
Professor, Psychiatry
Biography
Denise M. Sloan, Ph.D. is a psychologist and Associate Director in the Behavioral Science Division, National Center for PTSD. She is also a Professor of Psychiatry at Chobanian and Avedisian School of Medicine.
Her research expertise is in psychosocial treatments for PTSD and emotion in psychopathology. She has received funding from her work from several organizations, including the National Institute for Mental Health and Department of Veterans Affairs. Dr. Sloan is a member of several editorial boards including Behavior Therapy, Behaviour Research and Therapy, and Journal of Abnormal Psychology.
Other Positions
- VA Boston Healthcare System
Education
- Case Western Reserve University, PhD
- Case Western Reserve University, MA
- Stony Brook University, BA
Publications
- Published on 3/2/2024
Pless Kaiser A, Daks JS, Korsun L, Heintz H, Moye J, Sloan DM, Cook JM, Vogt D, Spiro A. Enhancing social functioning in older veterans with PTSD: Rationale and design of an intervention and initial RCT. Contemp Clin Trials. 2024 Apr; 139:107485. PMID: 38432471.
Read at: PubMed - Published on 2/15/2024
DeJesus CR, Trendel SL, Sloan DM. A systematic review of written exposure therapy for the treatment of posttraumatic stress symptoms. Psychol Trauma. 2024 Feb 15. PMID: 38358724.
Read at: PubMed - Published on 2/13/2024
Sloan DM. Editorial: State of the Journal. J Trauma Stress. 2024 Apr; 37(2):203-204. PMID: 38351369.
Read at: PubMed - Published on 1/9/2024
Meredith LS, Wong EC, Marx BP, Han B, Korn AR, Tobin JN, Cassells A, Williamson S, Franco M, Overa CC, Holder T, Lin TJ, Sloan DM. Design of a hybrid implementation effectiveness cluster randomized controlled trial of delivering written exposure therapy for PTSD in underserved primary care settings. Contemp Clin Trials. 2024 Mar; 138:107435. PMID: 38211725.
Read at: PubMed - Published on 11/14/2023
Lee DJ, Crowe ML, Weathers FW, Bovin MJ, Ellickson S, Sloan DM, Schnurr P, Keane TM, Marx BP. An Item Response Theory Analysis of the Clinician-Administered PTSD Scale for DSM-5 Among Veterans. Assessment. 2023 Nov 14; 10731911231202440. PMID: 37960836.
Read at: PubMed - Published on 11/11/2023
Stoycos SA, Straud CL, Stanley IH, Marx BP, Resick PA, Young-McCaughan S, Peterson AL, Sloan DM. Benchmarking secondary outcomes to posttraumatic stress disorder symptom change in response to cognitive processing and written exposure therapy for posttraumatic stress disorder. J Anxiety Disord. 2023 Dec; 100:102794. PMID: 37980801.
Read at: PubMed - Published on 11/8/2023
Shayani DR, Canale CA, Sloan DM, Hayes AM. Predictors of dropout in cognitive processing therapy for PTSD: An examination of in-session treatment processes. Behav Res Ther. 2023 Dec; 171:104428. PMID: 37952284.
Read at: PubMed - Published on 11/1/2023
Sloan DM, Marx BP, Acierno R, Messina M, Muzzy W, Gallagher MW, Litwack S, Sloan C. Written Exposure Therapy vs Prolonged Exposure Therapy in the Treatment of Posttraumatic Stress Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2023 Nov 01; 80(11):1093-1100. PMID: 37610727.
Read at: PubMed - Published on 9/26/2023
Alpert E, Sloan DM, Lee DJ, Cole TA, Shotwell Tabke C. Response to Sonis's (2023) commentary on Alpert et al.'s (2023) systematic review of mediators and mechanisms of PTSD treatments. Clin Psychol Rev. 2023 Dec; 106:102338. PMID: 37858387.
Read at: PubMed - Published on 7/20/2023
Thompson-Hollands J, Lunney CA, Sloan DM, Wiltsey Stirman S, Schnurr PP. Treatment length and symptom improvement in prolonged exposure and present-centered therapy for posttraumatic stress disorder: Comparing dose-response and good-enough level models in two manualized interventions. J Consult Clin Psychol. 2023 Oct; 91(10):596-605. PMID: 37471022.
Read at: PubMed
View 126 more publications: View full profile at BUMC